Atlanta, GA, United States of America

Guojing Sun



 

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2020

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Guojing Sun: Innovator in Cancer Research

Introduction

Guojing Sun is a prominent inventor based in Atlanta, GA, known for his significant contributions to cancer research through innovative chemical compounds. With a total of two patents, his work focuses on developing analogs that exhibit anti-proliferative activity against cancer cells.

Latest Patents

Sun's latest patents include "Anthraquinone analogs and methods of making and using thereof" and "Curcumin analogs and methods of making and using thereof." The first patent describes Rhein analogues that demonstrate anti-proliferative activity, particularly against cancer cells. These compounds feature a flat or planar ring system that facilitates non-covalent binding to DNA complexes, such as through intercalation. Additionally, the compounds may contain substituents that are alkylating moieties, electrophilic groups, or Michael acceptors, enhancing their effectiveness. The second patent outlines compounds with specific formulas and methods for their synthesis and application, further contributing to the field of cancer treatment.

Career Highlights

Guojing Sun has worked with notable institutions, including the Georgia State University Research Foundation and the University of Delhi. His research has significantly advanced the understanding of chemical compounds in the context of cancer therapy.

Collaborations

Sun has collaborated with esteemed colleagues, including Binghe Wang and Xiaochuan Yang, to further his research endeavors.

Conclusion

Guojing Sun's innovative work in developing cancer-fighting compounds showcases his dedication to advancing medical science. His contributions are vital in the ongoing battle against cancer, and his patents reflect a commitment to improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…